By rray, 12 September, 2023 Exclude Patient Type Detail Header No Detail Type Text Detail Text Moderate or severe acute illness w or w o fever GBS hx w in 6wk of a previous influenza vaccine dose LAIV3 additional precautions nbsp nbsp Influenza antivirals might interfere w LAIV3 if initiated 2wk after vaccination Pts who receive antivirals w in a specified time frame before receipt of LAIV3 48h for oseltamivir and zanamivir 5 days for peramivir an Patient Type Detail Header (Long) Precautions: